Regulatory guidelines and bioethics in regenerative dentistry: new FDA guidance for preclinical studies of bone graft materials
The development of regenerative dentistry and implantology in recent years has been accompanied by the active introduction of new bone graft materials, which, in turn, increases the requirements for their safety, efficacy, and ethical justification in preclinical studies. In this context, regulatory documents that establish unified standards for evaluating medical devices take on particular significance. […]
